{
    "title": "Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017",
    "content": "Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017 This bill amends title XI of the Social Security Act (SSAct) tonbsp, require the publicnbsp. Disclosure of certain information provided to the Department of Health and Human Services (HHS) by a pharmacy benefit manager (PBM)nbsp, that contracts with: (1) a prescription drugnbsp, plan (PDP) under Medicare ornbsp, Medicare Advantage (MA),nbsp. Or (2) a qualified health benefits plan offered through an exchange established under the Patient Protection and Affordable Care Act. nbsp. Specifically, HHS must publish on its website, with respect to each PBM, informationnbsp. Regarding: (1) the amount and type of rebates and discounts negotiated by the PBM and the extent to which these rebates and discounts are passed on to the plan sponsor, and (2) the difference between the amount paid by the plan sponsor to the PBM and the amount paid by the PBM to pharmacies. As a condition of participation as a contractornbsp, under Medicare or MA, a PBM must passnbsp, on tonbsp, anbsp. PDP sponsor a minimum percentage, as established by HHS, of the amount of rebates and discounts negotiated by the PBM that are attributable to patient utilization under the plan. The bill alsonbsp, amends title XVIII (Medicare) of the SSAct to modify requirementsnbsp, regarding enrollees' access to negotiated drug prices. nbsp, Current law requiresnbsp, a PDP sponsornbsp, to provide enrollees in Medicarenbsp, or MAnbsp, with access to negotiatednbsp, drug prices thatnbsp, account for rebates and discounts. The bill requiresnbsp, that, with respect to a covered drug,nbsp, anbsp, negotiated price nbsp, be provided at the point of sale."
}